The Miami Beach keloid specialist outlines why pairing surgical excision with superficial radiation therapy can reduce ...
Clinical Trials Arena on MSN
Mabwell doses first patient in phase II anti-IL-11 antibody trial
The first patient received dosing at Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine.
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Phase II clinical trial of its self-developed innovative anti-IL-11 ...
Discover the best expert-approved ways to stop ingrown hairs, from clever skincare ingredients to easy routines that actually ...
Researchers warn that climate, forest-based livelihoods and weak vector control fuel infections, while stigma and treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results